Ascent Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Ascent Group's PFE Position: Q1 2026 in Review
Ascent Group reduced its Pfizer (PFE) stake by 6.4% in Q1 2026, selling an estimated $334K and leaving 184,580 shares worth $5.18M. The position accounts for 0.18% of the portfolio, ranked #116.
Ascent Group first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Ascent Group held 184,580 shares of Pfizer worth $5.18M as of Q1 2026.
- Ascent Group sold 12,534 Pfizer shares in Q1 2026, an estimated $334K.
- Pfizer made up 0.18% of Ascent Group's portfolio in Q1 2026, its #116 holding.
- Ascent Group first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.